Cancer Clinical Trial -Werewolf Therapeutics- WTX-124

Cancer

Status:

Open

ClinicalTrials.gov:

NCT05479812

Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Drug

WTX-124, Pembrolizumab

Phase

Phase I

Condition

Advanced Solid Tumors

Keywords

IL-2, mRCC